
Keywords: cough; health-related quality of life; immunosuppressive therapy; interstitial lung disease; scleroderma; BDI; baseline dyspnea index; CYC; cyclophosphamide; Dlco; diffusing capacity of lung for carbon monoxide; FC; frequent cough; GERD; gastroesophageal